EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Evidence for common mechanisms of pathology between SHANK3 and other genes of Phelan‐McDermid syndrome

Andrew R Mitz, Luigi Boccuto iD, Audrey Thurm

Clinical Genetics · 2024

DOI: 10.1111/cge.14503 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Genetics, 2024. Verfasst von Andrew R Mitz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neuropsychology, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Nerve Tissue Proteins, Chromosome Disorders. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chromosome 22q13.3 deletion (Phelan‐McDermid) syndrome (PMS, OMIM 606232) is a rare genetic condition that impacts neurodevelopment. PMS most commonly results from heterozygous contiguous gene deletions that include the SHANK3 gene or likely pathogenic variants of SHANK3 (PMS‐ SHANK3 related). Rarely, chromosomal rearrangements that spare SHANK3 share the same general phenotype (PMS‐ SHANK3 unrelated). Very recent human and model system studies of genes that likely contribute to the PMS phenotype point to overlap in gene functions associated with neurodevelopment, synaptic formation, stress/inflammation and regulation of gene expression. In this review of recent findings, we describe the functional overlaps between SHANK3 and six partner genes of 22q13.3 ( PLXNB2 , BRD1 , CELSR1 , PHF21B , SULT4A1 , and TCF20 ), which suggest a model that explains the commonality between PMS‐ SHANK3 related and PMS‐ SHANK3 unrelated classes of PMS. These genes are likely not the only contributors to neurodevelopmental impairments in the region, but they are the best documented to date. The review provides evidence for the overlapping and likely synergistic contributions of these genes to the PMS phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nerve Tissue ProteinsChromosome DisordersHumansChromosome DeletionPhenotypeChromosomes, Human, Pair 22Transcription Factors

Stichwörter der Autor:innen

Phelan‐McDermid syndromegene expressioninflammationneurodevelopmentsynaptic function

Substanzen

Nerve Tissue ProteinsTCF20 protein, humanTranscription FactorsSHANK3 protein, human

Autor:innen und Institutionen

  • Laboratory of Neuropsychology, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA.
  • Healthcare Genetics and Genomics Interdisciplinary Doctoral Program, School of Nursing, College of Behavioral, Social and Health Sciences, Clemson University, Clemson, South Carolina, USA.
  • Neurodevelopmental and Behavioral Phenotyping Service, Office of the Clinical Director, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA.

ORCID-Profile: Luigi Boccuto

Förderung

  • Intramural NIH HHS

Zitieren

APA

Mitz, A. R., Boccuto, L., & Thurm, A. (2024). Evidence for common mechanisms of pathology between SHANK3 and other genes of Phelan‐McDermid syndrome. Clinical Genetics. https://doi.org/10.1111/cge.14503

Vancouver

Mitz AR, Boccuto L, Thurm A. Evidence for common mechanisms of pathology between SHANK3 and other genes of Phelan‐McDermid syndrome. Clinical Genetics. 2024. doi:10.1111/cge.14503

BibTeX
@article{Mitz2024,
  author = {Mitz, Andrew R and Boccuto, Luigi and Thurm, Audrey},
  title = {Evidence for common mechanisms of pathology between SHANK3 and other genes of Phelan‐McDermid syndrome},
  journal = {Clinical Genetics},
  year = {2024},
  doi = {10.1111/cge.14503}
}
Kostenlos starten →